B
Novo Nordisk A/S NVO
$124.23 $4.463.72%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Revenue 9.51B 8.58B 7.93B 7.69B 6.61B
Total Other Revenue -- -- -- -- --
Total Revenue 9.51B 8.58B 7.93B 7.69B 6.61B
Cost of Revenue 1.45B 1.42B 1.15B 1.18B 1.13B
Gross Profit 8.06B 7.16B 6.79B 6.51B 5.47B
SG&A Expenses 2.69B 2.06B 2.25B 1.94B 2.07B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -433.10K -14.31M 2.19M -4.75M -59.48M
Total Operating Expenses 5.44B 4.65B 4.44B 4.09B 4.15B
Operating Income 4.07B 3.93B 3.49B 3.60B 2.45B
Income Before Tax 3.99B 4.10B 3.54B 3.56B 2.24B
Income Tax Expenses 816.66M 815.64M 705.13M 709.33M 374.17M
Earnings from Continuing Operations 3.17B 3.28B 2.84B 2.85B 1.87B
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 3.17B 3.28B 2.84B 2.85B 1.87B
EBIT 4.07B 3.93B 3.49B 3.60B 2.45B
EBITDA 4.28B 4.30B 3.81B 3.85B 2.63B
EPS Basic 0.71 0.73 0.63 0.63 0.41
Normalized Basic EPS 0.59 0.57 0.49 0.50 0.34
EPS Diluted 0.71 0.73 0.63 0.63 0.41
Normalized Diluted EPS 0.58 0.57 0.49 0.49 0.34
Average Basic Shares Outstanding 4.46B 4.48B 4.49B 4.50B 4.51B
Average Diluted Shares Outstanding 4.48B 4.49B 4.50B 4.51B 4.52B
Dividend Per Share 0.92 0.00 0.44 -- 0.56
Payout Ratio 0.00% 59.75% 0.00% 92.55% 0.00%
Weiss Ratings